Axitinib Flops as Add-On in NSCLC Study (CME/CE)

VIENNA (MedPage Today) -- A once-promising small molecule did not improve treatment efficacy when added to standard platinum-based therapy for advanced non-small cell lung cancer, researchers reported. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2012/10/axitinib-flops-as-add-on-in-nsclc-study.html